Bio Blast Gains 9%, Company Will President Final Phase 2 Trial Data At Industry Conference
April 15, 2016 at 08:13 AM EDT
Shares of Bio Blast Pharma Ltd (NASDAQ: ORPN) were trading higher by more than 9 percent early Friday morning after the company ...
